Owlet, Inc. (OWLT)

Owlet, Inc. remains a buy as it evolves into a comprehensive pediatric health platform and consistently beats and raises revenue guidance. OWLT demonstrates strong revenue growth, improving operating leverage, and expanding high-margin subscription offerings, despite ongoing operating losses and tariff headwinds. Key growth catalysts include Owlet 360 subscriber expansion, BabySat healthcare partnerships, and a telehealth pilot, with international growth still in early stages.

LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (NYSE: OWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, today announced that on September 30, 2025, the Compensation Committee of its Board of Directors approved an equity inducement award to Jordan Thompson, the Company's Vice President and Corporate Controller. The award was made in connection with Mr. Thompson joining the Company as a material inducement to employment. The equity inducement award consists of 129,863 restricted.

LEHI, Utah, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Owlet, Inc. (NYSE:OWLT) has released the following notice: IN THE UNITED STATES DISTRICT COURTFOR THE CENTRAL DISTRICT OF CALIFORNIA IN RE OWLET, INC.

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (NYSE: OWLT) has released the following notice: IN THE UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA IN RE OWLET, INC. SHAREHOLDER DERIVATIVE LITIGATION Lead Case No. 2:24-cv-07258-FLA-PVC This Document Relates to:   ALL ACTIONS. NOTICE OF PROPOSED DERIVATIVE SETTLEMENT NOTICE OF PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE MATTERS, HEARING THEREON, AND RIGHT TO APPEAR TO: ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON.

JOHANNESBURG--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, this groundbreaking product enables parents to track Baby's live vital signs and receive real-time health notifications, delivering greater peace of mind. Designed for healthy babies between 0 and 18 months (2.5-13.6 kg), Dream Sock is a trusted.

LEHI, Utah--(BUSINESS WIRE)---- $owlt #dreamsock--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, this groundbreaking product enables parents to track Baby's live vital signs and receive real-time health notifications, delivering greater peace of mind. Designed for healthy babies between 0 and 18 months (2.5-13.6 kg), Dream Sock is a trusted t.

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces that Dream Sock™ has received official certification from Australia's Therapeutic Goods Administration (TGA), meeting rigorous standards required for medical devices in the region. "TGA certification of Dream Sock marks an important step forward in our global expansion, bringing more families worldwide access to the latest pediatric health monitoring technolo.

Owlet, Inc.(NYSE:OWLT ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Amanda Twede Crawford - Chief Financial Officer Jay Gentzkow - Vice President of Investor Relations Jonathan Harris - President Kurt Workman - Co-Founder, CEO & Director Conference Call Participants Alex Joseph Fuhrman - Lucid Capital Markets, LLC, Research Division Benjamin Charles Haynor - Lake Street Capital Markets, LLC, Research Division Boris Peaker - Unidentified Company Charles Rhyee - TD Cowen, Research Division Owen Ray Rickert - Northland Capital Markets, Research Division Operator Good afternoon. Thank you for attending today's Owlet Q2 '25 Earnings Conference Call.

Owlet (OWLT 10.00%), a digital health company specializing in smart infant monitoring, reported its second quarter 2025 results on August 7, 2025. The main headline was a significant outperformance, with GAAP revenue of $26.1 million in Q2 2025 easily beating the analyst estimate of $22.17 million.

Owlet, Inc. (OWLT) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to break-even earnings per share a year ago.

LEHI, Utah--(BUSINESS WIRE)---- $owlt #investorrelations--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced an agreement with a majority of the holders of the Company's Series A and Series B warrants to exchange their warrants for common stock. “We're very pleased to simplify our capital structure through today's announced warrant exchange,” said Jonathan Harris, Owlet's President. “The successful exchange of these warrants will be an important milestone that we be.

Owlet has rebounded from FDA-related setbacks, regaining approval and showing strong revenue growth, with new revenue highs and improved margins in 2024. Key growth drivers include FDA-cleared products, the new Owlet 360 subscription, international expansion, and healthcare partnerships, all supporting revenue. Risks remain with high SG&A costs, customer concentration, dilution, and regulatory uncertainties, but profitability is expected as the company scales.

LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) plans to announce second quarter 2025 financial results after market close on Thursday, August 7, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic).

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. has donated 250 of its FDA-cleared Dream Sock® smart baby monitors to March of Dimes' NICU Care Package Kit program.

Owlet, Inc. (NYSE:OWLT ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Jay Gentzkow - Vice President, Investor Relations Kurt Workman - Co-Founder & Chief Executive Officer Jonathan Harris - President & Chief Revenue Officer Amanda Twede Crawford - Chief Financial Officer Conference Call Participants Lucas Romanski - TD Cowen Colin Ricker - Northland Capital Ben Haynor - Lake Street Capital Markets Operator Good Afternoon, and thank you all for attending the Owlet Q1 2025 Earnings Conference Call. My name is Brika and I will be your moderator for today.

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), today reports financial results for the first quarter ended March 31, 2025.